Comparison of Ketamine and Esketamine in Patients Suffering From Fibromyalgia Syndrome.
Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
Ketamine and Esketamine intravenous perfusions can modulate chronic pain. The purpose of this
study is to determine if Ketamine or Esketamine are favorable for outpatients suffering from
fibromyalgia.